$RLFTF FC dd from ya-h-oo (copy)
The Clinical Trial
$RLFTF FC dd from ya-h-oo (copy)
The Clinical Trial site was officially updated to use Resolution of Respiratory Failure up to 28 days as the primary endpoint. The wording in everyone's mind before this update, I believe, was clear of respiratory failure in 7-10 days. This was why during Dr. J's second interview with Dr. Yo, everyone was so distressed to find out the interim review for 102 patient would be 4 weeks after 9/30 instead of 10 days.
I did a little digging. This version of endpoints has actually been there all along without much of our notice. In the Study Protocol document (dated August 15, 2020) of the EAP(NCT04453839 on ClinicalTrials site), the Statistical Methods section says:
- Primary endpoint: survival over 60 days by Kaplan Meier analysis
- Secondary endpoint: recovery from respiratory failure on cumulative probability distribution
- Secondary endpoint: NIAID 8 point ordinal scale
The first secondary endpoint became the primary endpoint in IV trial, the primary endpoint became the second secondary endpoint. So this change didn't come from the FDA. It has always been in the design of Dr. J's team. Now we can see the EAP and IV trial converge on their endpoints. This isn't revealed until almost the last minute. What a surprise!
A lot can be read into this. Here are my two cents. One is now I understand more what Dr. J meant by 'registration quality' when talking about EAP data. EAP having the same set of main endpoints is one aspect of it. Two is we should now have a pretty good feeling about the trial data. It will follow EAP footstep and will be impressive.
We will soon have two sets of data to support our EUA if the company go ahead and unblind the 102 interim data after full enrollment (102 is at 60 days as well). FDA please give Aviptadil the blessing in a timely manner so it can do its job!
1
Mondobiotech Holding AG Basel (RLFTF) Stock Research Links
$MJ
Scroll down for more posts ▼
Top 10 Most Recent News Articles
The Hidden Cost of Colorado's Dry Air Dry climate isn't just a seasonal inconvenience—it's a real hidden cost to living comfortably and healthily in Colorado. With winters colder than a brass monkey's tail and summers that don't offer much relief in terms of humidity, your home's air quality is on the front line. So, what's the financial tale here, and how do you come...
Continue Reading
Trouble Brews at D-Wave Quantum Smack in the middle of market chaos, D-Wave Quantum Inc. (NASDAQ: QBTS) seems to have hit a rather gnarly pothole. With disappointing revenue figures for Q2 of 2026—coming in at a measly $3.08 million, far below the expected range of $4.03 million to $4.08 million—investors have more than enough reasons to be irked. When the numbers...
Continue Reading
Why Pizza Is More Than Just Food They say a slice of pizza can tell a story. Whether it's a late-night snack amongst college buddies or the centerpiece of a family's Friday tradition, pizza unites like few others can. It morphs from a study aid into a tool for togetherness without skipping a beat, much like a chameleon of the food world. And no one understands this better...
Continue Reading
Investors Swim Against the Current With SMPL Picture this: You’re sipping your morning coffee, glancing through stocks, only to choke on your bagel when The Simply Good Foods Company (NASDAQ: SMPL) pops up with some less-than-palatable news. A class action is brewing, shouting out to investors who took the bait from October 24, 2024, to April 8, 2026. If you’re one of...
Continue Reading
Ajman: A Tourism Gem in the Making Swinging into the Arabian Travel Market 2026, Ajman isn't just a footnote in the UAE's tourism playbook anymore, it's gunning for the spotlight. There's a flurry of activity as the Ajman Department of Tourism, Culture and Media rolls up its sleeves to flaunt the emirate's kaleidoscope of attractions to the world's tourism brass. Going...
Continue Reading
Evolution of South-South Agricultural Cooperation Let's just say if there's a time to shine a spotlight on the arid lands of our world, it's now. The Global Drylands Congress 2026 in New Delhi put a sharp focus on scaling agricultural innovation across these thirsty regions. With climate change breathing down our necks, talking shop about food security isn't just for show...
Continue Reading
Unraveling Ellison's Bold Decision There's nothing like a sudden shift from a tech titan to make Wall Street sit up and take notice. Today, we got the word that Larry Ellison, Oracle's big gun as Executive Chair and CTO, has pulled the plug on his plan to sell Oracle stock. No dice, no distance covered under that plan. And he's made it crystal clear—selling isn't on his...
Continue Reading
Stepping into New Territory with SystImmune Amid the cacophony of biotech whispers and the marketplace hum, SystImmune is trotting out something that might just make the folks in lab coats raise an eyebrow. They’ve got new data for Iza-bren—none of that flashy PR chatter—but it's damn promising if you ask me. At the World Conference on Lung Cancer in Seoul,...
Continue Reading
China-Europe Trade Ties Continue to Tighten You ever watch a cargo ship glide into port and think, "There's a piece of the future right there”? Well, that's the scene at Poland’s Gdansk Port, now officially etched into the Silk Road Maritime route. This ain't just a couple of extra boats cutting through choppy waters—it's a great leap forward for a strained global...
Continue Reading
Preserving Our Natural Chompers Digging into the details of endodontic care, you realize how it's the unsung hero in the dental world. And let's face it, teeth don't get happier on their own when there's a problem on the inside. Dr. Christopher Joubert, a wiz on the endodontic front, spills the beans over at HelloNation about how essential these practices are in keeping...
Continue Reading
Top 5 Most Recently Viewed Articles
Recent Stock Sales by Tesla's Executives Tesla Inc. Chair Robyn Denholm has made headlines after selling approximately $33.7 million worth of the electric vehicle maker's stock. This transaction, as outlined in a filing with the Securities and Exchange Commission, marks an important moment for the company and its stakeholders. The Ongoing Trend of Insider Selling In...
Continue Reading
Kraig Labs and the Future of Sports Apparel As the world of sports apparel continues to evolve, Kraig Biocraft Laboratories (OTCQB: KBLB) firmly places itself at the forefront of innovation by delving into the remarkable properties of spider silk. This revolutionary material is not just a scientific fantasy but a functional solution aimed at enhancing athletic performance...
Continue Reading
Evolus, Inc. to Present at the Stifel Healthcare Conference Evolus, Inc. (NASDAQ: EOLS), a renowned beauty performance company, is preparing to engage in the Stifel Healthcare Conference. This event will be held in New York City, where key members from Evolus' management team will share their insights and developments in the beauty industry. Event Details The Evolus...
Continue Reading
Revolutionary Intruder Detainment System for Improved Safety In today's world, home security is a top priority, making innovative safety solutions essential. A creative individual from Chicago has developed an exciting detainment system designed to bolster security measures. This new invention, called HELP, can capture intruders in real-time and hold them until law...
Continue Reading
Danske Bank's Share Buy-Back Programme Overview Danske Bank has put forth a substantial share buy-back programme aimed at enhancing shareholder value. Announced recently, this initiative is set to buy back shares worth a staggering DKK 5 billion, covering a maximum of 45 million shares over a specified timeframe. The programme has generated significant interest among...
Continue Reading